問卷

TPIDB > Search Result > Clinical Trials List

Clinical Trials List

Protocol NumberNN9535-4114

2017-08-28 - 2019-10-02

Phase III

Terminated3

ICD-10E11

Type 2 diabetes mellitus

ICD-9250.00

Diabetes mellitus without mention of complication, Type II [non-insulin dependent type][NIDDM type] [ adult-onset type] or unspecified type, not stated as uncontrolled

  • Trial Applicant

    NOVO NORDISK PHARMA (TAIWAN) LTD.

  • Sponsor

  • Trial scale

    Multi-Regional Multi-Center

  • Update

    2025/08/20

Investigators and Locations

Principal Investigator Harn-Shen Chen Division of Endocrinology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

28 Stop recruiting

Audit

None

Principal Investigator 謝昌勳 Division of Endocrinology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Stop recruiting

Principal Investigator Yu-Yao Huang Division of Endocrinology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Stop recruiting

Audit

None

Condition/Disease

Objectives

Test Drug

Active Ingredient

Dosage Form

Dosage

Endpoints

Inclution Criteria

The Estimated Number of Participants

  • Taiwan

    50 participants

  • Global

    858 participants